Hypera declares BRL 0.26 dividend: 15 analysts rate Hypera stock Buy

Published on 10/02/2026 at 00:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hypera grew second-quarter revenue 8.50 percent to BRL 2.34 billion year over year. 15 analysts rate Hypera stock Buy with a BRL 29.60 target.

Hypera, BRHYPEACNOR0, Illustration mit AI erstellt.

Hypera (BRHYPEACNOR0) declared BRL 0.26 per share for the third quarter of 2026, while 15 analysts rate Hypera stock Buy in the latest consensus overview. The payout adds an income angle as the Brazilian drugmaker reports stronger second-quarter operating figures and continues to manage a substantial debt load.

Dividend adds a shareholder return

According to Bitget on September 24, 2026, Hypera declared BRL 0.26304 per share for the 2026 third quarter, rounded here to BRL 0.26. The shares traded with entitlement through September 28, 2026, giving the announcement a concrete date in the companys distribution calendar.

MarketScreener lists 15 analysts, a Buy consensus and an average BRL 29.60 target. Its listed reference price is BRL 24.37, placing the average target BRL 5.23 above that reference level, or 21.46 percent higher.

Revenue growth meets a higher bar

Hypera reported second-quarter 2026 net revenue of BRL 2.34 billion, up 8.50 percent from the same period a year earlier, according to ScanX. The report also puts EBITDA at BRL 755.0 million and the EBITDA margin at 32.30 percent for the quarter.

Net income increased 15.00 percent in the second quarter of 2026, while operating cash flow reached BRL 819.0 million. The combination matters because cash generation exceeded EBITDA by BRL 64.0 million, giving the company room to address financing costs while continuing product launches.

Debt remains central to valuation

ScanX reported net debt of BRL 5.90 billion, equal to 2.10 times trailing-twelve-month EBITDA, after a BRL 1.50 billion capital raise in the prior quarter. The same report said lower financial costs helped drive the year-over-year net income increase.

Hypera also approved a BRL 1.35 billion debenture issue to refinance debt, as ADVFN reported on September 9, 2026. That financing action places balance-sheet management beside revenue growth as a key measure of the equity story.

Hypera market value and listing

Hypera had a market capitalization of BRL 16.4 billion as of September 23, 2026. The company is listed on B3 under ticker HYPE3, and Global Banking and Finance Review identifies the security as Hypera S.A. with ISIN BRHYPEACNOR0.